• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人带状疱疹:临床、免疫学及治疗方面的考量

Zoster in the elderly: clinical, immunologic and therapeutic considerations.

作者信息

Harnisch J P

出版信息

J Am Geriatr Soc. 1984 Nov;32(11):789-93. doi: 10.1111/j.1532-5415.1984.tb06298.x.

DOI:10.1111/j.1532-5415.1984.tb06298.x
PMID:6094642
Abstract

Herpes zoster is common in the elderly. Persons over the age of 50 years have an attack rate double that of patients less than 50 years old. In the very aged, this rate nearly doubles again. The loss of cell-mediated immunity for the VZ virus appears to be the primary factor in the disruption of the dynamic containment process responsible for VZ virus latency within the sensory ganglion. Humoral immunity may play a role in the maintenance of latency, but the degree is unproven, except in the case of dissemination where loss of detectable antibodies seems to correlate with extradermatomal dissemination. Severe forms of the disease and its complications, e.g., postherpetic neuralgia, are likely among the elderly. Direct immunofluorescent staining or cytologic examination is useful for early diagnosis, and serologic changes can document the confusing clinical entity of zoster sine herpete.

摘要

带状疱疹在老年人中很常见。50岁以上的人群发病率是50岁以下患者的两倍。在高龄人群中,这一发病率几乎又会翻倍。针对水痘-带状疱疹病毒(VZ病毒)的细胞介导免疫丧失似乎是破坏负责VZ病毒在感觉神经节内潜伏的动态控制过程的主要因素。体液免疫可能在维持潜伏状态中起作用,但程度尚未得到证实,除了在播散性病例中,可检测抗体的丧失似乎与皮外播散相关。严重形式的疾病及其并发症,如带状疱疹后神经痛,在老年人中很可能出现。直接免疫荧光染色或细胞学检查有助于早期诊断,血清学变化可记录无疹性带状疱疹这一令人困惑的临床实体。

相似文献

1
Zoster in the elderly: clinical, immunologic and therapeutic considerations.老年人带状疱疹:临床、免疫学及治疗方面的考量
J Am Geriatr Soc. 1984 Nov;32(11):789-93. doi: 10.1111/j.1532-5415.1984.tb06298.x.
2
[Reactivation of herpes zoster infection by varicella-zoster virus].[水痘-带状疱疹病毒引起的带状疱疹感染再激活]
Med Pregl. 1999 Mar-May;52(3-5):125-8.
3
Clinical and immunologic features of recurrent herpes zoster (HZ).复发性带状疱疹(HZ)的临床和免疫学特征。
J Am Acad Dermatol. 2016 Nov;75(5):950-956.e1. doi: 10.1016/j.jaad.2016.05.037. Epub 2016 Jul 26.
4
Antibody responses to varicella-zoster virus and the role of antibody in host defense.针对水痘-带状疱疹病毒的抗体反应及抗体在宿主防御中的作用。
Am J Med Sci. 1981 Jul-Aug;282(1):12-7. doi: 10.1097/00000441-198107000-00002.
5
An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.水痘带状疱疹病毒皮肤试验反应与疱疹后皮肤症状和带状疱疹相关疼痛的严重程度呈负相关,但抗体则不是。
J Dermatol Sci. 2013 Mar;69(3):243-9. doi: 10.1016/j.jdermsci.2012.10.015. Epub 2012 Nov 5.
6
Should patients with zoster receive zoster immune globulin?带状疱疹患者应该接受带状疱疹免疫球蛋白治疗吗?
JAMA. 1975 Dec 8;234(10):1049-51.
7
Selective decline in cellular immune response to varicella-zoster in the elderly.老年人对水痘-带状疱疹的细胞免疫反应选择性下降。
Neurology. 1980 Jun;30(6):582-7. doi: 10.1212/wnl.30.6.582.
8
Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia.带状疱疹的局部免疫反应和全身细胞因子反应:与带状疱疹后神经痛发生的关系
Clin Exp Immunol. 2003 Feb;131(2):318-23. doi: 10.1046/j.1365-2249.2003.02061.x.
9
Herpes zoster: epidemiology, clinical features, and management.带状疱疹:流行病学、临床特征及管理
South Med J. 1984 Sep;77(9):1149-56. doi: 10.1097/00007611-198409000-00025.
10
Varicella-zoster virus-specific immunity after herpes zoster.带状疱疹后的水痘-带状疱疹病毒特异性免疫。
J Infect Dis. 1991 Apr;163(4):873-5. doi: 10.1093/infdis/163.4.873.

引用本文的文献

1
Herpesvirus Infections and Risk of Parkinson's Disease.疱疹病毒感染与帕金森病风险。
Neurodegener Dis. 2020;20(2-3):97-103. doi: 10.1159/000512874. Epub 2021 Jan 18.
2
Suspected Herpes Zoster-associated Encephalitis during Treatment with Oral Tofacitinib in Alopecia Universalis.全秃患者口服托法替布治疗期间疑似带状疱疹相关性脑炎。
Int J Trichology. 2018 Nov-Dec;10(6):286-288. doi: 10.4103/ijt.ijt_87_18.
3
Efficacy of varicella (VZV) vaccination: an update for the clinician.水痘(VZV)疫苗的疗效:给临床医生的最新信息
Ther Adv Vaccines. 2016 Jan;4(1-2):20-31. doi: 10.1177/2051013616655980. Epub 2016 Jan 1.
4
Varicella Zoster Virus in the Nervous System.神经系统中的水痘带状疱疹病毒
F1000Res. 2015 Nov 26;4. doi: 10.12688/f1000research.7153.1. eCollection 2015.
5
Varicella zoster virus vaccines: potential complications and possible improvements.水痘带状疱疹病毒疫苗:潜在并发症及可能的改进措施
Virol Sin. 2014 Oct;29(5):265-73. doi: 10.1007/s12250-014-3516-9. Epub 2014 Oct 24.
6
The variegate neurological manifestations of varicella zoster virus infection.水痘-带状疱疹病毒感染的多样神经表现。
Curr Neurol Neurosci Rep. 2013 Sep;13(9):374. doi: 10.1007/s11910-013-0374-z.
7
Complications of varicella zoster virus reactivation.水痘带状疱疹病毒再激活的并发症。
Curr Treat Options Neurol. 2013 Aug;15(4):439-53. doi: 10.1007/s11940-013-0246-5.
8
Presentation and management of herpes zoster (shingles) in the geriatric population.老年人群中带状疱疹(缠腰龙)的临床表现与管理
P T. 2013 Apr;38(4):217-27.
9
Varicella zoster virus latency.水痘带状疱疹病毒潜伏
Future Virol. 2011 Mar;6(3):341-355. doi: 10.2217/fvl.10.90.
10
Clinical and molecular aspects of varicella zoster virus infection.水痘带状疱疹病毒感染的临床和分子学方面
Future Neurol. 2009 Jan 1;4(1):103-117. doi: 10.2217/14796708.4.1.103.